Paraneoplastic Neuropathy

Peripheral Neuropathy

Volumn 2, Issue , 2005, Pages 2471-2487

  Spies, Judith M ^a   McLeod, James G ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33646679129     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-9491-7.50113-7     Document Type: Chapter

References (164)

1. Ahmed M.N., Carpenter S. Autonomic neuropathy and carcinoma of the lung. Can. Med. Assoc. J. 1975, 113:410.
2. Altermatt H.J., Rodriguez M., Scheithauer B.W., et al. Paraneoplastic anti-Purkinje and type-I anti-neuronal nuclear antibodies bind selectively to central, peripheral and autonomic nervous system cells. Lab. Invest. 1991, 65:412.
3. Anderson N.E., Rosenblum M.K., Graus F., et al. Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer. Neurology 1988, 38:1391.
4. Ansari J., Nagabhushan N., Syed R., et al. Small cell lung cancer associated with anti-Hu paraneoplastic sensory neuropathy and peripheral nerve microvasculitis: case report and literature review. Clin. Oncol. (R. Coll. Radiol.) 2004, 16:71.
5. Antoine J.C., Absi L., Honnorat J., et al. Antiamphiphysin antibodies are associated with various paraneoplastic neurological syndromes and tumors. Arch. Neurol. 1999, 56:172.
6. 18F]Fluorode-oxyglucose positron emission tomography in the diagnosis of cancer in patients with paraneoplastic neurological syndrome and anti-Hu antibodies. Ann. Neurol. 2000, 48:105.
7. Antoine J.C., Honnorat J., Camdessanche J.P., et al. Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy. Ann. Neurol. 2001, 49:214.
8. Antoine J.C., Honnorat J., Vocanson C., et al. Posterior uveitis, paraneoplastic encephalomyelitis and auto-antibodies reacting with developmental protein of brain and retina. J. Neurol. Sci. 1993, 117:215.
9. Antoine J.C., Mosnier J.F., Absi L., et al. Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies. J. Neurol. Neurosurg. Psychiatry 1999, 67:7.
10. Antoine J.C., Mosnier J.F., Lapras J., et al. Chronic inflammatory demyelinating polyneuropathy associated with carcinoma. J. Neurol. Neurosurg. Psychiatry 1996, 60:188.
11. Batson O.A., Fantle D.M., Stewart J.A. Paraneoplastic encephalomyelitis: dramatic response to chemotherapy alone. Cancer 1992, 69:1291.
12. Bechich S., Graus F., Arboix A., et al. Anti-Hu-associated paraneoplastic sensory neuropathy and breast cancer. J. Neurol. 2000, 247:552.
13. Bell C.E., Seetharam S. Identification of the Schwann cell as a peripheral nervous system cell possessing a differentiation antigen expressed by a human lung tumor. J. Immunol. 1977, 118:826.
14. Benyahia B., Liblau R., Merle-Beral H., et al. Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies. Ann. Neurol. 1999, 45:162.
15. Bird S.J., Brown M.J., Shy M.E., et al. Chronic inflammatory demyelinating polyneuropathy associated with malignant melanoma. Neurology 1996, 46:822.
16. Blaes F., Strittmatter M., Merkelbach S., et al. Intravenous immunoglobulins in the therapy of paraneoplastic neurological disorders. J. Neurol. 1999, 246:299.
17. Blumenthal D., Schochet S., Gutmann L., et al. Small-cell carcinoma of the lung presenting with paraneoplastic peripheral nerve microvasculitis and optic neuropathy. Muscle Nerve 1998, 21:1358.
18. Bohnen N.I., Cheshire W.P., Lennon V.A., Van Den Berg C.J. Plasma exchange improves function in a patient with ANNA-1 seropositive paraneoplastic autonomic neuropathy [abstract]. Neurology 1997, 48:A131.
19. Brain L., Croft P.B., Wilkinson M. Motor neurone disease as a manifestation of neoplasm (with a note on the course of classical motor neurone disease). Brain 1965, 88:479.
20. Brain R. The neurological complications of neoplasms. Lancet 1963, 1:179.
21. Brain R., Henson R.A. Neurological syndromes associated with carcinoma: the carcinomatous neuromyopathies. Lancet 1958, 2:971.
22. Brashear H.R., Caccamo D.V., Heck A., et al. Localization of antibody in the central nervous system of a patient with paraneoplastic encephalomyeloneuritis. Neurology 1991, 41:1583.
23. Briellmann R.S., Sturzenegger M., Gerber H.A., et al. Autoantibody-associated sensory neuronopathy and intestinal pseudo-obstruction without detectable neoplasia. Eur. Neurol. 1996, 36:369.
24. Budde-Steffen C., Anderson N.E., Rosenblum M.K., et al. An anti-neuronal autoantibody in paraneoplastic opsoclonus. Ann. Neurol. 1988, 23:528.
25. Budde-Steffen C., Anderson N.E., Rosenblum M.K., et al. Expression of an antigen in small cell lung carcinoma lines detected by antibodies from patients with paraneoplastic dorsal root ganglionopathy. Cancer Res. 1988, 48:430.
26. Byk T., Dobransky T., Cifuentes-Diaz C., et al. Identification and molecular characterization of Unc-33-like phos-phoprotein (Ulip), a putative mammalian homolog of the axonal guidance-associated unc-33 gene product. J. Neurosci. 1996, 16:688.
27. Camdessanche J.P., Antoine J.C., Honnorat J., et al. Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies: a clinical and electrophysiological study of 20 patients. Brain 2002, 125:166.
28. Camerlingo M., Nemni R., Ferraro B., et al. Malignancy and sensory neuropathy of unexplained cause: a prospective study of 51 patients. Arch. Neurol. 1998, 55:981.
29. Carpentier A.F., Rosenfeld M.R., Delattre J.Y., et al. DNA vaccination with HuD inhibits growth of a neuroblastom in mice. Clin. Cancer Res. 1998, 4:2819.
30. Cavaletti G., Bogliun G., Marzorati L., et al. The incidence and course of paraneoplastic neuropathy in women with epithelial ovarian cancer. J. Neurol. 1991, 238:371.
31. Chalk C.H., Windebank A.J., Kimmel D.W., et al. The distinctive clinical features of paraneoplastic sensory neuronopathy. Can. J. Neurol. Sci. 1992, 19:346.
32. Chiappa K.H., Young R.H. A case of paracarcinomatous pandysautonomia [abstract]. Neurology 1973, 23:423.
33. Chinn J.S., Schuffler M.D. Paraneoplastic visceral neuropathy as a cause of severe gastrointestinal motor dysfunction. Gastroenterology 1988, 95:1279.
34. Croft P.B., Urich H., Wilkinson M. Peripheral neuropathy of sensorimotor type associated with malignant disease. Brain 1967, 90:31.
35. Croft P.B., Wilkinson M. Carcinomatous neuromyopathy: its incidence in patients with carcinoma of the lung and carcinoma of the breast. Lancet 1963, 1:184.
36. Croft P.B., Wilkinson M. The incidence of carcino-matous neuromyopathy in patients with various types of carcinoma. Brain 1965, 88:427.
37. Croft P.B., Wilkinson M. The course and prognosis in some types of carcinomatous neuromyopathy. Brain 1969, 92:1.
38. Dalmau J., Furneaux H.M., Cordon-Cardo C., et al. The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues. Am. J. Pathol. 1992, 141:881.
39. Dalmau J., Furneaux H.M., Gralla R.J., et al. Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer-a quantitative Western blot analysis. Ann. Neurol. 1990, 27:544.
40. Dalmau J., Furneaux H.M., Rosenblum M.K., et al. Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy. Neurology 1991, 41:1757.
41. Dalmau J., Graus F., Rosenblum M.K., et al. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy: a clinical study of 71 patients. Medicine (Baltimore) 1992, 71:59.
42. Dalmau J., Posner J.B. Neurologic paraneoplastic antibodies (anti-Yo; anti-Hu; anti-Ri): the case for a nomenclature based on antibody and antigen specificity. Neurology 1994, 44:2241.
43. De Giorgio R., Barbara G., Stanghellini V., et al. Clinical and morphofunctional features of idiopathic myenteric ganglionitis underlying severe intestinal motor dysfunction: a study of three cases. Am. J. Gastroenterol. 2002, 97:2454.
44. Denny-Brown D. Primary sensory neuropathy with muscular changes associated with carcinoma. J. Neurol. Neurosurg. Psychiatry 1948, 11:73.
45. Dick D.J., Harris J.B., Falkous G., et al. Neuronal anti-nuclear antibody in paraneoplastic sensory neuronopathy. J. Neurol. Sci. 1988, 85:1.
46. Donofrio P.D., Alessi A.G., Albers J.W., et al. Electrodiagnostic evolution of carcinomatous sensory neuronopathy. Muscle Nerve 1989, 12:508.
47. Dropcho E.J. Antiamphiphysin antibodies with small-cell lung carcinoma and paraneoplastic encephalomyelitis. Ann. Neurol. 1996, 39:659.
48. Eggers C., Hagel C., Pfeiffer G. Anti-Hu-associated paraneoplastic sensory neuropathy with peripheral nerve demyelination and microvasculitis. J. Neurol. Sci. 1998, 155:178.
49. Elrington G.M., Murray N.M., Spiro S.G., et al. Neurological paraneoplastic syndromes in patients with small cell lung cancer: a prospective survey of 150 patients. J. Neurol. Neurosurg. Psychiatry 1991, 54:764.
50. Evans B.K., Fagan C., Arnold T., et al. Paraneoplastic motor neuron disease and renal cell carcinoma: improvement after nephrectomy. Neurology 1990, 40:960.
51. Evans C.C., Kaufman H.D. Unusual presentation of seminoma of the testis. Br. J. Surg. 1971, 58:703.
52. Ferraci F., Fassetta G., Butler M.H., et al. A novel anti-neuronal antibody in a motor neuron syndrome associated with breast cancer. Neurology 1999, 53:852.
53. Folli F., Solimena M., Cofiell R., et al. Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer. N. Engl. J. Med. 1993, 328:546.
54. Forsyth P.A., Dalmau J., Graus F., et al. Motor neuron syndromes in cancer patients. Ann. Neurol. 1997, 41:722.
55. Fuller G.N., Spies J.M., Pollard J.D., et al. Demyelinating neuropathies triggered by melanoma immunotherapy. Neurology 1994, 44:2404.
56. Furneaux H.F., Reich L., Posner J.B. Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. Neurology 1990, 40:1085.
57. Gerl A., Storck M., Schalhorn A., et al. Paraneoplastic chronic intestinal pseudoobstruction as a rare complication of bronchial carcinoid. Gut 1992, 33:1000.
58. Goshima Y., Nakamura F., Strittmatter P., et al. Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature 1995, 376:509.
59. Graus F., Abos J., Roquer J., et al. Effect of plasmapheresis on serum and CSF autoantibody levels in CNS paraneoplastic syndromes. Neurology 1990, 40:1621.
60. Graus F., Bonaventura I., Uchuya M., et al. Indolent anti-Hu-associated paraneoplastic sensory neuropathy. Neurology 1994, 44:2258.
61. Graus F., Cordon-Cardo C., Posner J.B. Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology 1985, 35:538.
62. Graus F., Dalmau J., Rene R., et al. Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. J. Clin. Oncol. 1997, 15:2866.
63. Graus F., Elkon K.B., Cordon-Cardo C., et al. Sensory neuronopathy and small cell lung cancer: antineuronal antibody that also reacts with the tumor. Am. J. Med. 1986, 80:45.
64. Graus F., Ferrer I., Lamarca J. Mixed carcinomatous neuropathy in patients with lung cancer and lymphoma. Acta Neurol. Scand. 1983, 68:40.
65. Graus F., Illa I., Agusti M., et al. Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model. J. Neurol. Sci. 1991, 106:82.
66. Graus F., Keime-Guibert F., Rene R., et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001, 124:1138.
67. Graus F., Rene R. Paraneoplastic neuropathies. Eur. Neurol. 1993, 33:279.
68. Graus F., Ribalta T., Campo E., et al. Immunohistochemical analysis of the immune reaction in the nervous system in paraneoplastic encephalomyelitis. Neurology 1990, 40:219.
69. Graus F., Vega F., Delattre J.Y., et al. Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. Neurology 1992, 42:536.
70. Greenlee J.E., Brashear H.R. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Ann. Neurol. 1983, 14:609.
71. Gultekin S.H., Rosenfeld M.R., Voltz R., et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000, 123:1481. Pt 7.
72. Halls J., Bredkjaer C., Friis M.L. Guillain-Barre syndrome: diagnostic criteria, epidemiology, clinical course and prognosis. Acta Neurol. Scand. 1988, 78:118.
73. Hawley R.J., Cohen M.H., Saini N., et al. The carcinomatous neuromyopathy of oat cell lung cancer. Ann. Neurol. 1980, 7:65.
74. Henson R.A., Hoffman H.L., Urich H. Encephalo-myelitis with carcinoma. Brain 1965, 88:449.
75. Henson R.A., Russell D.S., Wilkinson M. Carcinomatous neuropathy and myopathy: a clinical and pathological study. Brain 1954, 77:82.
76. Henson R.A., Urich H. Encephalomyelitis with cancer. Cancer and the Nervous System 1982, 314. Blackwell Scientific Publications, Oxford, GBR. R.A. Henson, H. Urich (Eds.).
77. Hildebrand J., Coers C. The neuromuscular function in patients with malignant tumours: electromyographic and histological study. Brain 1967, 90:67.
78. Honnorat J., Antoine J.C., Derrington E., et al. Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes. J. Neurol. Neurosurg. Psychiatry 1996, 61:270.
79. Hormigo A., Lieberman F. Nuclear localization of anti-Hu antibody is not associated with in vitro cytotoxicity. J. Neuroimmunol. 1994, 55:205.
80. Horwich M.S., Cho L., Porro R.S., et al. Subacute sensory neuropathy: a remote effect of carcinoma. Ann. Neurol. 1977, 2:7.
81. Ichimura M., Yamamoto M., Kobayashi Y., et al. Tissue distribution of pathological lesions and Hu antigen expression in paraneoplastic sensory neuronopathy. Acta Neuropathol. (Berl.) 1998, 95:641.
82. Ivy H.K. Renal sodium loss and bronchogenic carcinoma: associated autonomic neuropathy. Arch. Intern. Med. 1961, 108:47.
83. Jean W.C., Dalmau J., Ho A., et al. Analysis of the IgG subclass distribution and inflammatory infiltrates in patients with anti-Hu-associated paraneoplastic encephalomyelitis. Neurology 1994, 44:140.
84. Johnson P.C., Rolak L.A., Hamilton R.H., et al. Paraneoplastic vasculitis of nerve: a remote effect of cancer. Ann. Neurol. 1979, 5:437.
85. Keime-Guibert F., Graus F., Fleury A., et al. Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J. Neurol. Neurosurg. Psychiatry 2000, 68:479.
86. Khwaja S., Sripathi N., Ahmad B.K., et al. Paraneoplastic motor neuron disease with type 1 Purkinje cell antibodies. Muscle Nerve 1998, 21:943.
87. Kloos L., Sillevis S.P., Ang C.W., et al. Paraneoplastic ophthalmoplegia and subacute motor axonal neuropathy associated with anti-GQ1b antibodies in a patient with malignant melanoma. J. Neurol. Neurosurg. Psychiatry 2003, 74:507.
88. Konanc D.A., O'Neill B.P., Caselli R.J., Lennon V.A. Peripheral neuropathic presentation in 3 patients with seropositivity for type 1 anti-Purkinje cell antibodies (PCA-1) and ovarian or related Müllerian carcinoma [abstract]. Neurology 1995, 45(Suppl 4):A320.
89. Krarup C., Crone C. Neurophysiological studies in malignant disease with particular reference to involvement of peripheral nerves. J. Neurol. 2002, 249:651.
90. Kudo M., Nogoshi T. Immunoreactive myelin basic protein in tumour cells associated with carcinomatous neuropathy. Am. J. Clin. Pathol. 1985, 84:741.
91. Lenman J.A., Fleming A.M., Robertson M.A., et al. Peripheral nerve function in patients with bronchial carcinoma: comparison with matched controls and effects of treatment. J. Neurol. Neurosurg. Psychiatry 1981, 44:54.
92. Lennon V.A. Paraneoplastic autoantibodies: the case for a descriptive generic nomenclature. Neurology 1994, 44:2236.
93. Lennon V.A., Ermilov L.G., Szurszewski J.H., et al. Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease. J. Clin. Invest. 2003, 111:907.
94. Lennon V.A., Manley H.A., Kim K., Parisi J.E. Amphiphysin antibodies: a paraneoplastic serological marker of breast and lung cancer related encephalomyeloradiculoneuritides but not classical stiff man syndrome [abstract]. Neurology 1997, 48(Suppl. 1):A434.
95. Lennon V.A., Sas D.F., Busk M.F., et al. Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. Gastroenterology 1991, 100:137.
96. Lhermitte F., Gautier J.C., Escourolle R., et al. Orthostatic hypotension and peripheral neuropathy in the course of bronchial carcinoma. Presse Med. 1970, 78:257.
97. Lhermitte F., Gray F., Lyon-Caen O., et al. Paralysis of digestive tract with lesions of myenteric plexuses: a new paraneoplastic syndrome [author's transl.]. Rev. Neurol. (Paris) 1980, 136:825.
98. Lin K.P., Kwan S.Y., Chen S.Y., et al. Generalized neuropathy in Taiwan: an etiologic survey. Neuroepidemiology 1993, 12:257.
99. Lipton R.B., Galer B.S., Dutcher J.P., et al. Large and small fibre type sensory dysfunction in patients with cancer. J. Neurol. Neurosurg. Psychiatry 1991, 54:706.
100. Lucchinetti C.F., Kimmel D.W., Lennon V.A. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology 1998, 50:652.
101. Luque F.A., Furneaux H., Ferziger R., et al. Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann. Neurol. 1991, 29:241.
102. Manley G.T., Smitt P.S., Dalmau J., et al. Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites. Ann. Neurol. 1995, 38:102.
103. McNamara B., Boniface S.J., Ray J., et al. Paraneoplastic sensory neuropathy and Purkinje cell antibodies. Muscle Nerve 1999, 22:1466.
104. Molinuevo J.L., Graus F., Serrano C., et al. Utility of anti-Hu antibodies in the diagnosis of paraneoplastic sensory neuropathy. Ann. Neurol. 1998, 44:976.
105. Moll J.W., Markusse H.M., Henzen-Logmans S.C., et al. Anti-neuronal antibodies in Sjogren's syndrome and in paraneoplastic neurological disease. Lancet 1994, 343:1299.
106. Moody J.F. Electrophysiological investigations into the neurological complications of carcinoma. Brain 1965, 88:1023.
107. Mowzoon N., Bradley W.G. Successful immunosuppressant therapy of severe progressive cerebellar degeneration and sensory neuropathy: a case report. J. Neurol. Sci. 2000, 178:63.
108. Nemni R., Camerlingo M., Fazio R., et al. Serum antibodies to Purkinje cells and dorsal root ganglia neurons in sensory neuronopathy without malignancy. Ann. Neurol. 1993, 34:848.
109. Noronha A.B., Harper J.R., Ilyas A.A., et al. Myelin-associated glycoprotein shares an antigenic determinant with a glycoprotein of human melanoma cells. J. Neurochem. 1986, 47:1558.
110. Notermans N.C., Wokke J.H., Franssen H., et al. Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients. J. Neurol. Neurosurg. Psychiatry 1993, 56:1066.
111. Oh S.J. Paraneoplastic vasculitis of the peripheral nervous system. Neurol. Clin. 1997, 15:849.
112. Oh S.J., Dropcho E.J., Claussen G.C. Anti-Hu-associated paraneoplastic sensory neuropathy responding to early aggressive immunotherapy: report of two cases and review of literature. Muscle Nerve 1997, 20:1576.
113. Oh S.J., Slaughter R., Harrell L. Paraneoplastic vasculitic neuropathy: a treatable neuropathy. Muscle Nerve 1991, 14:152.
114. Ogilvie H. Large-intestine colic due to sympathetic deprivation. Br. Med. J. 1948, 2:671.
115. Pardi D.S., Miller S.M., Miller D.L., et al. Paraneoplastic dysmotility: loss of interstitial cells of Cajal. Am. J. Gastroenterol. 2002, 97:1828.
116. Park D.M., Johnson R.H., Crean G.P., et al. Orthostatic hypotension in bronchial carcinoma. Br. Med. J. 1972, 3:510.
117. Peng S.S., Chen C.Y., Xu N., et al. RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J. 1998, 17:3461.
118. Pittock S.J., Lucchinetti C.F., Lennon V.A. Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann. Neurol. 2003, 53:580.
119. Plonquet A., Gherardi R.K., Creange A., et al. Oligoclonal T-cells in blood and target tissues of patients with anti-Hu syndrome. J. Neuroimmunol. 2002, 122:100.
120. Pourmand R., Maybury B.G. AAEM Case Report #31: paraneoplastic sensory neuronopathy. Muscle Nerve 1996, 19:1517.
121. 18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders. Brain 2001, 124:2223.
122. Rijnders B., Decramer M. Reversibility of paraneoplastic bilateral diaphragmatic paralysis after nephrectomy for renal cell carcinoma. Ann. Oncol. 2000, 11:221.
123. Saiz A., Dalmau J., Butler M.H., et al. Anti-amphiphysin I antibodies in patients with paraneoplastic neurological disorders associated with small cell lung carcinoma. J. Neurol. Neurosurg. Psychiatry 1999, 66:214.
124. Saleh M.N., Khazaeli M.B., Wheeler R.H., et al. Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma. Cancer Res. 1992, 52:4342.
125. Sanchez-Guerrero J., Gutierrez-Urena S., Vidaller A., et al. Vasculitis as a paraneoplastic syndrome: report of II cases and review of the literature. J. Rheumatol. 1990, 17:1458.
126. Schuffler M.D., Baird H.W., Fleming C.R., et al. Intestinal pseudo-obstruction as the presenting manifestation of small-cell carcinoma of the lung: a paraneoplastic neuropathy of the gastrointestinal tract. Ann. Intern. Med. 1983, 98:129.
127. Scully R.E., Mark E.J., McNeely W.F., et al. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 20-1997: a 74-year-old man with progressive cough, dyspnea, and pleural thickening. N. Engl. J. Med. 1997, 336:1895.
128. Shy G.M., Silverstein I. A study of the effects upon the motor unit by remote malignancy. Brain 1965, 88:515.
129. Siemsen J.K., Meister L. Bronchogenic carcinoma associated with severe orthostatic hypotension. Ann. Intern. Med. 1963, 58:669.
130. Sillevis Smitt P., Grefkens J., de Leeuw B., et al. Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy. J. Neurol. 2002, 249:745.
131. Sillevis-Smitt P., Manley G., Moll J.W., et al. Pitfalls in the diagnosis of autoantibodies associated with paraneoplastic neurologic disease. Neurology 1996, 46:1739.
132. Sillevis Smitt P.A., Manley G.T., Posner J.B. Immunization with the paraneoplastic encephalomyelitis antigen HuD does not cause neurologic disease in mice. Neurology 1995, 45:1873.
133. Sodhi N., Camilleri M., Camoriano J.K., et al. Autonomic function and motility in intestinal pseudoobstruction caused by paraneoplastic syndrome. Dig. Dis. Sci. 1989, 34:1937.
134. Spring P.J., Krupka E., Spies J.M. Post-infectious sensory neuropathy responding to intravenous immunoglobulin [abstract]. J. Peripher. Nerv. Syst. 2001, 6:179.
135. SuzGBRi M., Kimura H., Tachibana I., et al. Improvement of anti-Hu-associated paraneoplastic sensory neuropathy after chemoradiotherapy in a small cell lung cancer patient. Intern. Med. 2001, 40:1140.
136. Szabo A., Dalmau J., Manley G., et al. HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell 1991, 67:287.
137. Tanaka K., Tanaka M., InuzGBRa T., et al. Cytotoxic T lymphocyte-mediated cell death in paraneoplastic sensory neuronopathy with anti-Hu antibody. J. Neurol. Sci. 1999, 163:159.
138. Tanaka K., Tanaka M., Onodera O., et al. Passive transfer and active immunization with the recombinant leucine-zipper (Yo) protein as an attempt to establish an animal model of paraneoplastic cerebellar degeneration. J. Neurol. Sci. 1994, 127:153.
139. Tanaka K., Tanaka M., Onodera O., et al. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss. Clin. Neurol. Neurosurg. 1995, 97:95.
140. Thomas J.P., Shields R. Associated autonomic dysfunction and carcinoma of the pancreas. Br. Med. J. 1970, 4:32.
141. Torvik A., Berntzen A.E. Necrotizing vasculitis without visceral involvement: postmortem examination of three cases with affection of skeletal muscles and peripheral nerves. Acta Med. Scand. 1968, 184:69.
142. Trojaborg W., Frantzen E., Andersen I. Peripheral neuropathy and myopathy associated with carcinoma of the lung. Brain 1969, 92:71.
143. Uchuya M., Graus F., Vega F., et al. Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies. J. Neurol. Neurosurg. Psychiatry 1996, 60:388.
144. van Oosterhout A.G., vande Pol M., ten Velde G.P., Twijnstra A. Neurologic disorders in 203 consecutive patients with small cell lung cancer: results of a longitudinal study. Cancer 1996, 77:1434.
145. Vega F., Graus F., Chen Q.M., et al. Intrathecal synthesis of the anti-Hu antibody in patients with paraneoplastic encephalomyelitis or sensory neuronopathy: clinical-immunologic correlation. Neurology 1994, 44:2145.
146. Verma A., Berger J.R., Snodgrass S., et al. Motor neuron disease: a paraneoplastic process associated with anti-Hu antibody and small-cell lung carcinoma. Ann. Neurol. 1996, 40:112.
147. Vernino S., Adamski J., Kryzer T.J., et al. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology 1998, 50:1806.
148. Vernino S., Lennon V.A. Neuronal ganglionic acetylcholine receptor autoimmunity. Ann. N. Y. Acad. Sci. 2003, 998:211.
149. Vernino S., Low P.A., Fealey R.D., et al. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N. Engl. J. Med. 2000, 343:847.
150. Vernino S., Low P.A., Lennon V.A. Experimental autoimmune autonomic neuropathy. J. Neurophysiol. 2003, 90:2053.
151. Verschuuren J.J., Dalmau J., Hoard R., et al. Paraneoplastic anti-Hu serum: studies on human tumor cell lines. J. Neuroimmunol. 1997, 79:202.
152. Vincent D., Dubas F., Hauw J.J., et al. Nerve and muscle microvasculitis in peripheral neuropathy: a remote effect of cancer?. J. Neurol. Neurosurg. Psychiatry 1986, 49:1007.
153. Voltz R., Dalmau J., Posner J.B., et al. T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis. Neurology 1998, 51:1146.
154. Wang L.H., Strittmatter S.M. A family of rat CRMP genes is differentially expressed in the nervous system. J. Neurosci. 1996, 16:6197.
155. Wanschitz J., Hainfellner J.A., Kristoferitsch W., et al. Ganglionitis in paraneoplastic subacute sensory neuronopathy: a morphologic study. Neurology 1997, 49:1156.
156. Wechsler I.S., Sapirstein M.R., Stein A. Primary and symptomatic amyotrophic lateral sclerosis. Am. J. Med. Sci. 1944, 208:70.
157. Weiss M.D., Luciano C.A., Semino-Mora C., et al. Molecular mimicry in chronic inflammatory demyelinating polyneuropathy and melanoma. Neurology 1998, 51:1738.
158. Wilkinson M., Urich H., Croft P.B. The remote effects of cancer on the nervous system. Proc. R. Soc. Med. 1967, 60:683.
159. Wilkinson P.C. Serological findings in carcinomatous neuropathy. Lancet 1964, 41:1301.
160. Windebank A.J., Blexrud M.D., Dyck P.J., et al. The syndrome of acute sensory neuropathy: clinical features and electrophysiologic and pathologic changes. Neurology 1990, 40:584.
161. Wolmorans M., Shakir T., Ridley S.A. An unusual presentation of paraneoplastic neuropathy. Anaesthesia 1999, 54:616.
162. Yagi Y., InuzGBRa T., Takada K., et al. Changes in anti-HuD antibody titers in the long-term course in paraneoplastic sensory neuropathy. Eur. Neurol. 1997, 37:122.
163. Younger D.S. Motor neuron disease and malignancy. Muscle Nerve 2000, 23:658.
164. Yu Z., Kryzer T.J., Griesmann G.E., et al. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann. Neurol. 2001, 49:146.